Archive
Proactive news snapshot: Block Energy, H&T Group, ClearStar …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Shield Therapeutics PLC
LON:STX
Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer ® /Feraccru ® (ferric maltol). The group has launched Accrufer® in the US and Feraccru ® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand. Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical for the development and commercialization of Accrufer ® / Feraccru ® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co in the Republic of Korea, and with KYE Pharmaceuticals in Canada.
175 stories · page 8 of 9
Archive
Proactive news snapshot: ECSC Group, Anglesey Mining, Sirius Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Trans-Siberian Gold announces record quarterly production
A look at the day's major movers, including IGas Energy, Egdon Resources, Mobile Streams, GYG Group, Dillistone, Connect Group and Non-Standard Finance
Shield Therapeutics appoints Karis as chairman
Karis has been on the board for three years already and chairs the remuneration committee
Archive
FTSE 100 finishes in red as China growth worries hit global equities
Top laggard on Footsie was oil services giant Wood Group, which shed 4.09% to 524.80p
Archive
Proactive news snapshot: accesso Technology, Braveheart Investment, Thor Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
VR Education zooms past price target after ENGAGE commercial release
A look at the day's major movers, featuring GAME, WANdisco, Mediazest, Purplebricks and Sports Direct
US FDA to make decision on Shield Therapeutics’ Feraccru drug by end of July
The US is a huge and potentially lucrative market that Shield is understandably keen to crack
Archive
Proactive news snapshot: Faron Pharma, Itaconix, Eco Atlantic Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Faron Pharmaceuticals, Diversified Gas & Oil, Mkango Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Interserve weak as Kier Group cash call comments spark concerns for constructors
A look at some of the London market's biggest risers and fallers on Monday
Shield Therapeutics' Feraccru to be considered for US market by the FDA
Feraccru already has EU approval while in Switzerland the drug can be used for iron deficiency anaemia in adults with inflammatory bowel disease
FTSE 100 clings on to triple-digit gain
The Footsie looked destined to finish well off the top but still sporting a handsome gain following a weekend of deals at the G20 and Opec meetings
Mission Marketing Group shares step up, United Carpets declines
A look at some of the biggest risers and fallers in the UK market on Wednesday
Investments and investor services
Midatech Pharma doubles as biotech stocks excited by sector takeover moves
A look at some of the biggest risers and fallers in London on Wednesday.
Zinc Media on the front foot after CEO and finance chief buy shares
A look at some of the top risers and fallers in London today
Investments and investor services
FTSE 100 closes in red amid trader tensions but Tesco soars
FTSE 100 closed in the red - down around nine points at 7,257
Archive
Tesco's results to be a "positive catalyst" for the share price
Updates are expected from Tesco, ASOS, PageGroup and McCarthy & Stone
Archive
Retailers and recruiters in focus as Tesco, ASOS, Hays and PageGroup report
The week ahead includes full-year results from Tesco and Saga, interims from ASOS, WH Smith and McCarthy & Stone, and trading updates from Robert Walters, Hays and PageGroup